RE:RE:RE:RE:Tilray Brands German Market by
Ventura2020 wrote: Ventura2020 wrote:
Maersk wrote: "Unlimited production in country now for Tilray, Aurora and Demecan."
And any other company that wants to grow cannabis in Germany. The goal is to reduce Germany's reliance on imports, and since Cansativa is the sole distributor for German-grown cannabis, it begs the question of how much market share will remain for CC Pharma, or what the overall medical market will be post-legalization.
From the European Cannabis Association:
"As a preliminary assessment, it can be assumed that, while the medicinal cannabis market in Germany might also stagnate or slightly decrease after a potential legalization of cannabis for recreational use, it is certainly not exposed to fluctuations as high as other international markets."
Maersk, please list all the "others" that are producing in Germany.
Did you know recreational cannabis is delayed in Germany. Maybe 5 years?
Maersk - (2/18/2024 8:02:18 AM)
RE:Tilray Brands German Market by
"Unlimited production in country now for Tilray, Aurora and Demecan."
And any other company that wants to grow cannabis in Germany.
Germany has so far issued licences to cultivate medical cannabis to Aurora, Demecan and Tilray. These licence holders currently produce only small quantities whilst cumulatively capable of producing around 80m tonnes a year.
In a recent paper domestic cultivator Demecan argued that, due to legal constraints outlined below, its adult-use market would have to be supplied solely by German-based producers, such as itself.
This also appears to be the emerging position of the Traffic Light Coalition with leaked drafts of its proposals published, today, indicating the country will be reliant on domestic cultivation
As Maersk stated, Canstavia has the market sewn up in Germany with access to over 3000 pharmacies and 300,000 patients.
Tilray, Aurora and Demecan can cultivate 80m tons of medicinal Cannabis in Country, combined. The only 3 with a licence to cultivate in Country.
There were 79 applicants to cultivate and 3 where chosen in the end.
The biggest and most unexpected change for Germany will, however, certainly be that once the law comes into force, cannabis for medical purposes will no longer be subject to the extremely strict rules of the BtmG, but rather will be dealt with under a new Cannabis Act. This eases regulation on medicinal cannabis – eg, a narcotics prescription will no longer be required in addition to the normal RX prescription.